Endra Life SciencesNDRA
13F holders, Q1 2025 (March 31)2holders −2
1new positions
3sold out
$4.10avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Endra Life Sciences Inc. (NDRA) in their 13F filings, down 2 from Q4 2024. 1 opened new positions and 3 sold out. The largest holders were Tower Research Capital LLC (TRC) ($5K) and Bank of America Corp. ($16).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5K |
| Exits | 3 | $695 |
All 13F filers, Q4 2024 → Q1 2025: 1,130 shares bought and 111 shares sold, net +1,019 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,130 | $5K |
| Bank of America Corp. | 0.00% | No change | 4 | $16 |
"% of holder's portfolio" is NDRA's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.